Correction: Sustained anti-BCR–ABL activity with pH responsive imatinib mesylate loaded PCL nanoparticles in CML cells
Abstract
Correction for ‘Sustained anti-BCR–ABL activity with pH responsive imatinib mesylate loaded PCL nanoparticles in CML cells’ by Barbara Cortese et al., Med. Chem. Commun, 2015, 6, 212–221.